Global Oncology Solution Market Research Report 2024

Publication ID:

PB507248769

Publication Date:

July 25, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

IT Services [2]

Computing & Electronics [3]

Description:

The global Oncology Solution market was valued at US$ 2913 million in 2023 and is anticipated to reach US$ 5024.9 million by 2030, witnessing a CAGR of 8.1% during the forecast period 2024-2030.
North American market for Oncology Solution is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Oncology Solution is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Oncology Solution in Medical Oncology is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Oncology Solution include The Chartis Group, McKesson, Cerner, BCG, Magellan Rx Management, Cardinal Health, GE Healthcare, Philips Healthcare and eviCore, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Oncology Solution, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oncology Solution.
Report Scope
The Oncology Solution market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Oncology Solution market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Oncology Solution companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
The Chartis Group
McKesson
Cerner
BCG
Magellan Rx Management
Cardinal Health
GE Healthcare
Philips Healthcare
eviCore
Canon Medical Systems
Roche
GenomOncology
B. Braun Medical
Carelon Insights
Diagn贸stica Longwood
Innovative Oncology Solutions
Segment by Type
Operation
Chemotherapy
Radiotherapy
Other
Segment by Application
Medical Oncology
Radiation Oncology
Surgical Oncology
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Oncology Solution companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Oncology Solution Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Operation
1.2.3 Chemotherapy
1.2.4 Radiotherapy
1.2.5 Other
1.3 Market by Application
1.3.1 Global Oncology Solution Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Medical Oncology
1.3.3 Radiation Oncology
1.3.4 Surgical Oncology
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Oncology Solution Market Perspective (2019-2030)
2.2 Oncology Solution Growth Trends by Region
2.2.1 Global Oncology Solution Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Oncology Solution Historic Market Size by Region (2019-2024)
2.2.3 Oncology Solution Forecasted Market Size by Region (2025-2030)
2.3 Oncology Solution Market Dynamics
2.3.1 Oncology Solution Industry Trends
2.3.2 Oncology Solution Market Drivers
2.3.3 Oncology Solution Market Challenges
2.3.4 Oncology Solution Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Oncology Solution Players by Revenue
3.1.1 Global Top Oncology Solution Players by Revenue (2019-2024)
3.1.2 Global Oncology Solution Revenue Market Share by Players (2019-2024)
3.2 Global Oncology Solution Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Oncology Solution Revenue
3.4 Global Oncology Solution Market Concentration Ratio
3.4.1 Global Oncology Solution Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Oncology Solution Revenue in 2023
3.5 Oncology Solution Key Players Head office and Area Served
3.6 Key Players Oncology Solution Product Solution and Service
3.7 Date of Enter into Oncology Solution Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Oncology Solution Breakdown Data by Type
4.1 Global Oncology Solution Historic Market Size by Type (2019-2024)
4.2 Global Oncology Solution Forecasted Market Size by Type (2025-2030)
5 Oncology Solution Breakdown Data by Application
5.1 Global Oncology Solution Historic Market Size by Application (2019-2024)
5.2 Global Oncology Solution Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Oncology Solution Market Size (2019-2030)
6.2 North America Oncology Solution Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Oncology Solution Market Size by Country (2019-2024)
6.4 North America Oncology Solution Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Oncology Solution Market Size (2019-2030)
7.2 Europe Oncology Solution Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Oncology Solution Market Size by Country (2019-2024)
7.4 Europe Oncology Solution Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Oncology Solution Market Size (2019-2030)
8.2 Asia-Pacific Oncology Solution Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Oncology Solution Market Size by Region (2019-2024)
8.4 Asia-Pacific Oncology Solution Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Oncology Solution Market Size (2019-2030)
9.2 Latin America Oncology Solution Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Oncology Solution Market Size by Country (2019-2024)
9.4 Latin America Oncology Solution Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Oncology Solution Market Size (2019-2030)
10.2 Middle East & Africa Oncology Solution Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Oncology Solution Market Size by Country (2019-2024)
10.4 Middle East & Africa Oncology Solution Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 The Chartis Group
11.1.1 The Chartis Group Company Detail
11.1.2 The Chartis Group Business Overview
11.1.3 The Chartis Group Oncology Solution Introduction
11.1.4 The Chartis Group Revenue in Oncology Solution Business (2019-2024)
11.1.5 The Chartis Group Recent Development
11.2 McKesson
11.2.1 McKesson Company Detail
11.2.2 McKesson Business Overview
11.2.3 McKesson Oncology Solution Introduction
11.2.4 McKesson Revenue in Oncology Solution Business (2019-2024)
11.2.5 McKesson Recent Development
11.3 Cerner
11.3.1 Cerner Company Detail
11.3.2 Cerner Business Overview
11.3.3 Cerner Oncology Solution Introduction
11.3.4 Cerner Revenue in Oncology Solution Business (2019-2024)
11.3.5 Cerner Recent Development
11.4 BCG
11.4.1 BCG Company Detail
11.4.2 BCG Business Overview
11.4.3 BCG Oncology Solution Introduction
11.4.4 BCG Revenue in Oncology Solution Business (2019-2024)
11.4.5 BCG Recent Development
11.5 Magellan Rx Management
11.5.1 Magellan Rx Management Company Detail
11.5.2 Magellan Rx Management Business Overview
11.5.3 Magellan Rx Management Oncology Solution Introduction
11.5.4 Magellan Rx Management Revenue in Oncology Solution Business (2019-2024)
11.5.5 Magellan Rx Management Recent Development
11.6 Cardinal Health
11.6.1 Cardinal Health Company Detail
11.6.2 Cardinal Health Business Overview
11.6.3 Cardinal Health Oncology Solution Introduction
11.6.4 Cardinal Health Revenue in Oncology Solution Business (2019-2024)
11.6.5 Cardinal Health Recent Development
11.7 GE Healthcare
11.7.1 GE Healthcare Company Detail
11.7.2 GE Healthcare Business Overview
11.7.3 GE Healthcare Oncology Solution Introduction
11.7.4 GE Healthcare Revenue in Oncology Solution Business (2019-2024)
11.7.5 GE Healthcare Recent Development
11.8 Philips Healthcare
11.8.1 Philips Healthcare Company Detail
11.8.2 Philips Healthcare Business Overview
11.8.3 Philips Healthcare Oncology Solution Introduction
11.8.4 Philips Healthcare Revenue in Oncology Solution Business (2019-2024)
11.8.5 Philips Healthcare Recent Development
11.9 eviCore
11.9.1 eviCore Company Detail
11.9.2 eviCore Business Overview
11.9.3 eviCore Oncology Solution Introduction
11.9.4 eviCore Revenue in Oncology Solution Business (2019-2024)
11.9.5 eviCore Recent Development
11.10 Canon Medical Systems
11.10.1 Canon Medical Systems Company Detail
11.10.2 Canon Medical Systems Business Overview
11.10.3 Canon Medical Systems Oncology Solution Introduction
11.10.4 Canon Medical Systems Revenue in Oncology Solution Business (2019-2024)
11.10.5 Canon Medical Systems Recent Development
11.11 Roche
11.11.1 Roche Company Detail
11.11.2 Roche Business Overview
11.11.3 Roche Oncology Solution Introduction
11.11.4 Roche Revenue in Oncology Solution Business (2019-2024)
11.11.5 Roche Recent Development
11.12 GenomOncology
11.12.1 GenomOncology Company Detail
11.12.2 GenomOncology Business Overview
11.12.3 GenomOncology Oncology Solution Introduction
11.12.4 GenomOncology Revenue in Oncology Solution Business (2019-2024)
11.12.5 GenomOncology Recent Development
11.13 B. Braun Medical
11.13.1 B. Braun Medical Company Detail
11.13.2 B. Braun Medical Business Overview
11.13.3 B. Braun Medical Oncology Solution Introduction
11.13.4 B. Braun Medical Revenue in Oncology Solution Business (2019-2024)
11.13.5 B. Braun Medical Recent Development
11.14 Carelon Insights
11.14.1 Carelon Insights Company Detail
11.14.2 Carelon Insights Business Overview
11.14.3 Carelon Insights Oncology Solution Introduction
11.14.4 Carelon Insights Revenue in Oncology Solution Business (2019-2024)
11.14.5 Carelon Insights Recent Development
11.15 Diagn贸stica Longwood
11.15.1 Diagn贸stica Longwood Company Detail
11.15.2 Diagn贸stica Longwood Business Overview
11.15.3 Diagn贸stica Longwood Oncology Solution Introduction
11.15.4 Diagn贸stica Longwood Revenue in Oncology Solution Business (2019-2024)
11.15.5 Diagn贸stica Longwood Recent Development
11.16 Innovative Oncology Solutions
11.16.1 Innovative Oncology Solutions Company Detail
11.16.2 Innovative Oncology Solutions Business Overview
11.16.3 Innovative Oncology Solutions Oncology Solution Introduction
11.16.4 Innovative Oncology Solutions Revenue in Oncology Solution Business (2019-2024)
11.16.5 Innovative Oncology Solutions Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

The Chartis Group
McKesson
Cerner
BCG
Magellan Rx Management
Cardinal Health
GE Healthcare
Philips Healthcare
eviCore
Canon Medical Systems
Roche
GenomOncology
B. Braun Medical
Carelon Insights
Diagn贸stica Longwood
Innovative Oncology Solutions

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂